What recent paediatric guidelines mean for drug developers
Drug Discovery World
JULY 25, 2023
The section on ‘clinical pharmacology considerations’ covers the physiological differences in paediatric patients that can be attributed to pharmacokinetics and pharmacodynamics of the compound/drug of interest. The guidance is for pharmaceutical companies conducting paediatric clinical trials in the EU using the PIP procedure.
Let's personalize your content